Filing Details
- Accession Number:
- 0001493152-23-032321
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-09-12 11:34:57
- Reporting Period:
- 2023-09-11
- Accepted Time:
- 2023-09-12 11:34:57
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1419554 | Bone Biologics Corp | BBLG | Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842) | 421743430 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1645093 | Jeff Frelick | C/O Bone Biologics Corp 2 Burlington Woods Dr. Suite 100 Burlington MA 01803 | Chief Executive Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2023-09-11 | 9,500 | $0.69 | 17,204 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.6799 to $0.6898, inclusive. Mr. Frelick undertakes to provide Bone Biologics Corporation, any security holder of Bone Biologics Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.